Commentary on: Physalin B attenuates liver fibrosis via suppressing
LAP2α-HDAC1 mediated deacetylation of GLI1 and hepatic stellate cell
activation
- Ralf Weiskirchen
15 Apr 2021Submitted to British Journal of Pharmacology 19 Apr 2021Submission Checks Completed
19 Apr 2021Assigned to Editor
22 Apr 2021Reviewer(s) Assigned
06 May 2021Review(s) Completed, Editorial Evaluation Pending
26 May 2021Editorial Decision: Revise Minor
27 May 20211st Revision Received
28 May 2021Submission Checks Completed
28 May 2021Assigned to Editor
28 May 2021Editorial Decision: Accept
